Recent antimalarial drug discovery has been a race to produce new medicines that
overcome emerging drug resistance, whilst considering safety and improving dosing …

Antiparasitics acting on endo-or ectoparasites represent the second largest segment of the
global animal health market, accounting for 23% of market share. However, relatively few …

Since the implementation of Roll Back Malaria, the widespread use of insecticide-treated
nets (ITNs) and indoor residual spraying (IRS) is thought to have played a major part in the …

In the context of stalling progress against malaria, resistance of mosquitoes to insecticides,
and residual transmission, mass drug administration (MDA) of ivermectin, an endectocide …

New vector-control tools are urgently needed to reduce malaria in areas where there is
significant transmission after deployment of indoor residual spraying (IRS) and insecticide …

Background Ivermectin is a potential new vector control tool to reduce malaria transmission.
Mosquitoes feeding on a bloodmeal containing ivermectin have a reduced lifespan …

Isoxazoline is a 5-membered heterocycle present in the active compounds of many
commercial veterinary anti-ectoparasitic products. The molecular target of isoxazolines is the …

Background: With insecticide resistance in malaria vectors spreading in geographical range
and intensity, there is a need for compounds with novel modes of action to maintain the …

Leishmaniosis is a vector-borne disease caused by protozoans of the genus Leishmania,
which are transmitted to vertebrates, including cats, through the bites of female …

The increasing occurrence of resistance to chemical insecticides in insect pest populations
is a serious threat to the integrity of current pest management strategies, and exploring new …